Nama's AI scorecard currently rates Merit Medical Systems Buy (6.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is MMSI's P/E ratio?

Merit Medical Systems trades at a trailing price-to-earnings ratio of 20.3.

When does MMSI report earnings?

Merit Medical Systems's next scheduled report is on Feb 23, 2027. Analysts expect EPS of $1.11.

What is the MMSI price target?

The median analyst price target from 12 analysts is $107.50, with a range of $90.00 – $123.00.

Is MMSI Shariah compliant?

Nama's AAOIFI-style screen reads Merit Medical Systems as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

Merit Medical Systems (MMSI)

Healthcare · Medical Instruments Supplies · NASDAQ

Merit Medical Systems (MMSI) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $5.23B, a trailing price-to-earnings ratio of 20.3 and a free-cash-flow yield of 4.0%. Over the most recent reported fiscal year, revenue grew 11.8% and free cash flow per share grew 14.2%. Nama's AI scorecard rates it Buy, 6.6 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Buy · 6.6/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Lagging · -1.6% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-21.7%

How far the last close sits under the highest price of the past five years.

Market cap	$5.23B
Trailing P/E	20.3
Price / book	3.1
Price / sales	3.2
FCF yield	4.0%
Dividend yield	—
Gross margin	49.5%
Operating margin	12.7%
Net margin	9.2%
Revenue growth (YoY)	+11.8%
Revenue growth (3-yr annual)	+9.6%
EPS growth (YoY)	+10.1%
FCF/share growth (YoY)	+14.2%
Beta	0.5
Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Instruments Supplies

MMSI earnings

Next report: Feb 23, 2027 (Q4 2026, EPS estimate $1.11). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 29, 2026	$1.12	$1.04	+7.7%	$416.24M
Q2 2026	Jul 30, 2026	$1.19	$0.96	+24.0%	$418.84M
Q1 2026	Apr 30, 2026	$0.94	$0.83	+13.2%	$381.88M
Q4 2025	Feb 24, 2026	$1.04	$0.95	+9.5%	$393.94M

MMSI analyst price target

Median target $107.50 from 12 analysts, ranging $90.00 – $123.00.

Medical Instruments Supplies peers

Ticker	Company	Market cap	P/E
ISRG	Intuitive Surgical	$159.96B	41.8
BDX	Becton, Dickinson	$57.71B	16.1
MDLN	Medline	$52.17B	25.1
ALC	Alcon	$36.23B	23.0
RMD	ResMed	$33.10B	20.4
WST	West Pharmaceutical Services	$27.85B	43.5
SOLV	Solventum	$15.38B	12.8
BAX	Baxter International	$13.34B	13.3

Explore live MMSI data on Nama Insights →

Recent Congressional trades

Merit Medical Systems trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Lisa McClain	House	Sell	$1,001 - $15,000	Oct 22, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025

MMSI FAQ

Is MMSI a buy?: Nama's AI scorecard currently rates Merit Medical Systems Buy (6.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is MMSI's P/E ratio?: Merit Medical Systems trades at a trailing price-to-earnings ratio of 20.3.
When does MMSI report earnings?: Merit Medical Systems's next scheduled report is on Feb 23, 2027. Analysts expect EPS of $1.11.
What is the MMSI price target?: The median analyst price target from 12 analysts is $107.50, with a range of $90.00 – $123.00.
Is MMSI Shariah compliant?: Nama's AAOIFI-style screen reads Merit Medical Systems as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.